Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
MJFF Publications
Donate Now
Access Resources

MJFF Publications

Open Access
51 - 60 of 6230 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2023
  • 2024
  • 2024
  • Epigenome‐wide association study, meta‐analysis, and multiscore profiling of whole blood in Parkinson's disease
    2025
    Summary Details
    OPEN
    Title: Epigenome‐wide association study, meta‐analysis, and multiscore profiling of whole blood in Parkinson's disease
    Author(s): Ingeborg Haugesag Lie, Manuela Tan, Maren Stolp Andersen, Mathias Toft, Lasse Pihlstrøm
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Vol: 12
    Issue #: 4
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.52292
    Best OA location URL:
    Citation Count: 0
  • Phenotyping the demographic and behavioral correlates of start hesitation in Parkinson's disease
    2025
    Summary Details
    OPEN
    Title: Phenotyping the demographic and behavioral correlates of start hesitation in Parkinson's disease
    Author(s): Christopher Coppin, Leonardo Bruzze, Peter G.R. Burke, Simon J.G. Lewis
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 135
    Issue #:
    Start Page: 107832
    End Page: 107832
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107832
    Best OA location URL: https://doi.org/10.1016/j.parkreldis.2025.107832
    Citation Count: 0
  • Retromer-dependent lysosomal stress in Parkinson's disease
    2024
    Summary Details
    OPEN
    Title: Retromer-dependent lysosomal stress in Parkinson's disease
    Author(s): Dario R. Alessi, Peter J. Cullen, Mark Cookson, Kalpana Merchant, Scott A. Small
    Journal Name: Philosophical Transactions of the Royal Society B: Biological Sciences
    Publisher: The Royal Society
    Vol: 379
    Issue #: 1899
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1098/rstb.2022.0376
    Best OA location URL:
    Citation Count: 6
  • Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer’s disease.
    2024
    Summary Details
    OPEN
    Title: Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer’s disease.
    Author(s): Carlos Cruchaga, Muhammad Ali, Yang-Lin Shen, Anh Do, Lihua Wang, Daniel Western, Menghan Liu, Aleksandra Beric, John Budde, Jen Gentsch, Sabrina Schindler, John C. Morris, David M. Holtzman, María Fernández, Agustín Ruiz, Ignacio Álvarez, Miquel Aguilar, Pau Pástor, Jarod Rutledge, Hamilton Oh, Edward N. Wilson, Yann Le Guen, Rayan Khalid, Chloe Robins, David Pulford, Laura Ibáñez, Tony Wyss‐Coray, Yun Ju Sung
    Journal Name:
    Publisher: Research Square Platform LLC
    Vol:
    Issue #:
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.21203/rs.3.rs-3631708/v1
    Best OA location URL:
    Citation Count: 0
  • Seeding Activity of Skin Misfolded Tau as a Biomarker for Tauopathies
    2024
    Summary Details
    OPEN
    Title: Seeding Activity of Skin Misfolded Tau as a Biomarker for Tauopathies
    Author(s): Zerui Wang, Ling Wu, Maria Gerasimenko, Tricia Gilliland, Steven A. Gunzler, Vincenzo Donadio, Rocco Liguori, Bin Xu, Wen-Quan Zou
    Journal Name:
    Publisher: Research Square Platform LLC
    Vol:
    Issue #:
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.21203/rs.3.rs-3968879/v1
    Best OA location URL:
    Citation Count: 0
  • Soluble and insoluble lysates from the human A53T mutant α-synuclein transgenic mouse model induces α-synucleinopathy independent of injection site
    2024
    Summary Details
    OPEN
    Title: Soluble and insoluble lysates from the human A53T mutant α-synuclein transgenic mouse model induces α-synucleinopathy independent of injection site
    Author(s): Michael K. Lee, Justin Barnes, Scott Vermilyea, Joyce Meints, Héctor Martínez
    Journal Name:
    Publisher: Research Square Platform LLC
    Vol:
    Issue #:
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.21203/rs.3.rs-3982325/v1
    Best OA location URL:
    Citation Count: 0
  • Clearing the Smoke: What Protects Smokers from Parkinson's Disease?
    2024
    Summary Details
    OPEN
    Title: Clearing the Smoke: What Protects Smokers from Parkinson's Disease?
    Author(s): Kenneth N. Rose, Michael A. Schwarzschild, Stephen N. Gomperts
    Journal Name: Movement Disorders
    Publisher: Wiley
    Vol: 39
    Issue #: 2
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29707
    Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29707
    Citation Count: 1
  • The identification of high-performing antibodies for Vacuolar protein sorting-associated protein 35 (hVPS35) for use in Western Blot, immunoprecipitation and immunofluorescence
    2023
    Summary Details
    OPEN
    Title: The identification of high-performing antibodies for Vacuolar protein sorting-associated protein 35 (hVPS35) for use in Western Blot, immunoprecipitation and immunofluorescence
    Author(s): Riham Ayoubi, Maryam Fotouhi, Kathleen Southern, Peter S. McPherson, Carl Laflamme
    Journal Name: F1000Research
    Publisher: F1000 Research Ltd
    Vol: 12
    Issue #:
    Start Page: 452
    End Page: 452
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.12688/f1000research.133696.1
    Best OA location URL:
    Citation Count: 4
  • Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson’s Disease: The International Linked Clinical Trials Initiative
    2024
    Summary Details
    OPEN
    Title: Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson’s Disease: The International Linked Clinical Trials Initiative
    Author(s): Richard Wyse, Tom Isaacs, Roger A. Barker, Mark Cookson, Ted M. Dawson, David Devos, David T. Dexter, Joy Duffen, Howard J. Federoff, Brian Fiske, Thomas Foltynie, Susan H. Fox, J. Timothy Greenamyre, Karl Kieburtz, Jeffrey H. Kordower, Dimitri Krainc, Helen Matthews, Darren J. Moore, Leah Mursaleen, Michael A. Schwarzschild, Simon Stott, David Sulzer, Per Svenningsson, Caroline M. Tanner, Camille Carroll, David K. Simon, Patrik Brundin
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Vol: 14
    Issue #: 4
    Start Page: 657
    End Page: 666
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-230363
    Best OA location URL:
    Citation Count: 1
  • Parkinson’s Disease is Predominantly a Genetic Disease
    2024
    Summary Details
    OPEN
    Title: Parkinson’s Disease is Predominantly a Genetic Disease
    Author(s): Shen‐Yang Lim, Christine Klein
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Vol: 14
    Issue #: 3
    Start Page: 467
    End Page: 482
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-230376
    Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd230376?id=journal-of-parkinsons-disease%2Fjpd230376
    Citation Count: 9
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.